Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
11:17am, Monday, 03'rd Oct 2022
AbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new indications. They are expected to drive revenues once Humira loses U.S. exclusivity in 2023.
Best Stocks To Buy During A Recession? 3 Defensive Stocks To Know
11:00am, Monday, 03'rd Oct 2022
Are these defensive stocks the best stocks to buy during a recession?
Bear Market Bargains: 3 Dividend Stocks to Buy Now
09:52am, Monday, 03'rd Oct 2022 The Motley Fool
All three of these stocks are attractively valued even though they're beating the market this year.
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
02:37pm, Sunday, 02'nd Oct 2022 The Motley Fool
Neither company has any reason to worry about a recession either.
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
10:37am, Sunday, 02'nd Oct 2022
Neither company has any reason to worry about a recession either.
Here's Why This Dividend King Is a Buy
12:10pm, Saturday, 01'st Oct 2022 The Motley Fool
Shares of this drugmaker have far outpaced the S&P 500 index in 2022.
Here's Why This Dividend King Is a Buy
08:10am, Saturday, 01'st Oct 2022
Shares of this drugmaker have far outpaced the S&P 500 index in 2022.
7 Analysts Have This to Say About AbbVie
12:31pm, Friday, 30'th Sep 2022 Benzinga
AbbVie (NYSE:ABBV) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
3
1
0
Last 30D
0
0
0
1
Tilray To Crater Over 30%? Here Are 5 Other Price Target Changes For Friday
12:28pm, Friday, 30'th Sep 2022 Benzinga
Barclays cut Tilray Inc (NASDAQ: TLRY) price target from $4.5 to $2. Barclays analyst Gaurav Jain maintained an Underweight rating on the stock. Tilray Brands shares rose 0.3% to $2.87 in pre-market
Where Will AbbVie Be in 3 Years?
10:00am, Friday, 30'th Sep 2022 The Motley Fool
This company has defied the bear market.
Where Will AbbVie Be in 3 Years?
06:00am, Friday, 30'th Sep 2022
This company has defied the bear market.
Where to Invest $10,000 Right Now
09:40am, Wednesday, 28'th Sep 2022 The Motley Fool
Don't let a volatile market keep you on the sidelines.
2 High-Yielding Dividend Stocks That Could Raise Their Payouts in October
01:57pm, Tuesday, 27'th Sep 2022 The Motley Fool
Should you buy these stocks before their dividend payments get another boost?
Is Loading Up on Passive Income Stocks Right Now a Good Idea?
11:17am, Tuesday, 27'th Sep 2022 The Motley Fool
Juicy yields aren't the only factor to consider.
Is iShares Core High Dividend ETF (HDV) a Strong ETF Right Now?
10:20am, Tuesday, 27'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for HDV
